Home › Digestive Diseases › NCT07490132
Endoscopic Retrograde Cholangiopancreatography
RecruitingObservational study
Endoscopic Retrograde Cholangiopancreatography Patient Registry
Who can join
Ages 15 and older · All sexes
Full eligibility criteria
Inclusion Criteria: Patients \>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025 Exclusion Criteria: Patients \<15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.
About the study
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
What is being tested
- Patients undergoing ERCPs at Methodist Dallas Medical Center (other)
Sponsor: Methodist Health System · Participants: 100 · Started: 2026-02
Contact the study team
- Crystee Cooper, DHEd · Phone: 214-947-1280
- Kavya Mankulangara · Phone: 214-947-4604
Official record on ClinicalTrials.gov — NCT07490132
Locations in the U.S.
| Texas | Methodist Dallas Medical Center- Clinical Research Institute, Dallas |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.